Proteolytic remodeling of the fibrin pseudocapsule of S. Aureus abscesses during aging

Active Grant Awarded

Award ID
FAG106819UMF9Y8
Recipient
Awarding agency
Obligated
$55,114

Award facts

Assistance listing
93.AG4 National Institute on Aging Training Individual Projects
Completion date 1% complete
Place of performance
Rochester, NY 14611, USA

Award details come from USAspending.gov.

Description

Abstract
Prosthetic joint infection (PJI) imposes a substantial burden on aging populations and our healthcare system, as this population has an increased incidence and severity due to immunocompromise, as well as higher rates of CO-morbidities (i.e., vascular disease and diabetes mellitus) and joint replacement. Moreover, age-related immunosenescence impedes containment of infection, leading to increased prevalence of bacteremia, resulting in sepsis and increased mortality. To understand this, extensive research has been done on abscesses formed by staphylococcus aureus, the primary pathogen in PJI. These abscesses, known as staphylococcal abscess communities (SACS), are crucial for protecting the host by containing the infection, clearing bacteria, and preventing sepsis. Unfortunately, S. Aureus evolved a unique pathogenic mechanism that involves the formation of a fibrin pseudocapsule during SAC establishment, which is thought to protect the bacteria from host immunity and standard-of-care (SOC) antibiotics. Thus, to further understand the paradoxical role of SACS, central questions in this field pertain to the host factors required for SAC stabilization and infection containment that are lost with aging, leading to bacterial dissemination and sepsis, and the development of antibiotics that can eradicate bacteria within mature SACS. To this end, preliminary data show aging weakens fibrin ring integrity in vitro and decreases SAC formation in vivo, suggesting an aging-associated mechanism that impairs infection containment and promotes dissemination. Interestingly, sitafloxacin can also uniquely disrupt fibrin pseudocapsule architecture and displays superior anti-SAC bactericidal potency compared to the ineffective SOC antibiotic for methicillin-resistant S. Aureus PJI, vancomycin. Given these findings, this proposal will test the hypothesis that the fibrin barrier of SACS is regulated by a dynamic balance between host fibrinogenic/fibrinolytic factors and bacterial proteases, which is perturbed by aging and sitafloxacin. Aim 1 will determine the effects of age on SAC dynamics and antimicrobial susceptibility, while aim 2 will elucidate the mechanism of sitafloxacin-induced fibrin ring degradation. By defining how aging alters the host factors that regulate fibrin ring formation, how bacterial proteases remodel this barrier, and how sitafloxacin eradicates SACS, this work will reveal novel therapeutic targets to disrupt SAC architecture and improve emerging treatments for PJI in aging populations.

Quick answers

Who received award FAG106819UMF9Y8?

FAG106819UMF9Y8 was awarded to University Of Rochester by National Institute on Aging (National Institutes of Health) on November 18, 2026.

How much is award FAG106819UMF9Y8 worth?

$55,114 has been obligated on FAG106819UMF9Y8.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award